Famvir (famciclovir) Tablets 125, 250, 500 mg December 2008

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- December 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.

Summary View

Sections Modified

PRECAUTIONS

• Drug Interactions
• Pregnancy Exposure Registry
• Nursing Mothers

ADVERSE REACTIONS

• Post Marketing Experience
  • .........SJS, TEN, cholestatic jaundice, abnormal LFTs....